<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of iron toxicity is well known in gastroenterology and hematology: <z:mp ids='MP_0005638'>hemochromatosis</z:mp>, <z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e> and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> represent iron toxicity models with evidence of serious damages to target organs such as the heart, the liver and <z:chebi fb="32" ids="24621">endocrine</z:chebi> tissues </plain></SENT>
<SENT sid="1" pm="."><plain>Iron chelation therapy has dramatically changed the survival rate of <z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e> since the introduction of desferoxamine with quantitative assessment of tissue <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> by magnetic resonance imaging </plain></SENT>
<SENT sid="2" pm="."><plain>Reperfusion <z:mp ids='MP_0001914'>hemorrhage</z:mp> is an independent predictor of left ventricular remodeling after <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0001914'>Hemorrhage</z:mp> may be a source of iron toxicity and a mediator of <z:mp ids='MP_0001845'>inflammation</z:mp>, directly contributing to left ventricular remodeling </plain></SENT>
<SENT sid="4" pm="."><plain>Iron chelation may potentially alleviate these cardiotoxic effects </plain></SENT>
<SENT sid="5" pm="."><plain>Cardiac magnetic resonance imaging can provide insights into miocrovascular obstruction, <z:mp ids='MP_0001914'>hemorrhage</z:mp> and iron chelation </plain></SENT>
</text></document>